netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 24 of 24


Details
LDL Link Added : NICE TA935: Secukinumab for treating moderate to severe hidradenitis suppurativa : https://www.nice.org.uk/guidance/ta935
14/03/2024 15:11:41
(DavidS )
UPD sitematrix Changed from 0 to
14/03/2024 15:11:00
(DavidS )
UPD FurtherInformation Changed from
  • Approved for the treatment of plaque psoriasis in line with NICE.
  • Approved for the treatment of moderate to severe plaque psoriasis in children and young people in line with NICE
to
14/03/2024 15:11:00
(DavidS )
UPD Secukinumab (Cosentyx®) NICE TA935
14/03/2024 15:11:00
(DavidS )
UPD Published from Draft Mode
03/11/2023 15:40:52
(LoweryM )
UPD sitematrix Changed from 0 to
03/11/2023 11:01:29
(DavidS )
UPD isDraft Changed from N to Y
03/11/2023 11:01:29
(DavidS )
UPD FurtherInformation Changed from
03/11/2023 11:01:29
(DavidS )
UPD Secukinumab (Cosentyx®) removal of MSK indication
03/11/2023 11:01:29
(DavidS )
UPD sitematrix Changed from 0 to
23/10/2023 10:56:43
(DavidS )
UPD FurtherInformation Changed from
23/10/2023 10:56:43
(DavidS )
UPD Secukinumab (Cosentyx®) updated formatting
23/10/2023 10:56:43
(DavidS )
LDL Link Added : NICE TA734: Secukinumab for treating moderate to severe plaque psoriasis in children and young people : https://www.nice.org.uk/guidance/ta734
16/12/2021 15:48:41
(DavidS )
UPD sitematrix Changed from 0 to
16/12/2021 15:48:18
(DavidS )
UPD FurtherInformation Changed from
  • Approved for the treatment of plaque psoriasis in line with NICE.
  • Approved for the treatment of non-radiographic axial spondyloarthritis in line with NICE
to
16/12/2021 15:48:18
(DavidS )
UPD Secukinumab (Cosentyx®) NICE TA734
16/12/2021 15:48:18
(DavidS )
LDL Link Added : NICE TA719: Secukinumab for treating non-radiographic axial spondyloarthritis : https://www.nice.org.uk/guidance/ta719
16/12/2021 15:03:54
(DavidS )
UPD sitematrix Changed from 0 to
16/12/2021 15:03:30
(DavidS )
UPD FurtherInformation Changed from
  • Approved for the treatment of plaque psoriasis in line with NICE.
to
16/12/2021 15:03:30
(DavidS )
UPD Secukinumab (Cosentyx®) NICE TA719
16/12/2021 15:03:30
(DavidS )
UPD Secukinumab (Cosentyx®) updated
25/04/2017 16:36:47
(LoweryM )
UPD Secukinumab 150mg injection (Cosentyx®) b
30/01/2017 11:22:58
(WhitehallJ )
UPD Secukinumab 150mg injection (Cosentyx®) b
19/01/2017 07:58:24
(DavidS )
UPD Secukinumab (Cosentyx®) build
20/12/2016 10:57:46
(DavidS )

 

 
netFormulary